6-Bromo-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid, 97%, 5g

2-(2-Methyl-1H-imidazol-1-yl)ethanamine dihydrochloride, 95.0%, 25g

N-Ethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

1-tert-Butyl 3-methyl 3-ethyl-4-oxopiperidine-1,3-dicarboxylate, 97%, 5g

4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 5g

1,1-Dioxidotetrahydrothien-3-ylamine, 95.0%, 5g

Methyl 3-(p-tolyl)isoxazole-5-carboxylate, 5g

(Z)-5-(5-FLUORO-2-OXO-2,3-DIHYDRO-1H-INDOL-3-YLIDENEMETHYL)-2,4-DIMETHYL-N-[2-(1-PYRROLIDINYL)ETHYL]-1H-PYRROLE-3-CARBOXAMIDE, 97.0%, 10mg

2-ethyl-5-(4H-1,2,4-triazol-4-yl)aniline, 95.0%, 5g

N-(4-(Trifluoromethyl)phenethyl)acetamide, 95%, 2g

2-Bromo-4-tert-butylbenzenesulfonyl chloride, 95%, 5g

SPE Cartridges CHROMAFIX® HLB (60 µm), 0.8 ml, Medium, 50 Piece(s)

3-Acetylcoumarin>98.0%(GC)25g